Entheon Biomedical
Entheon Biomedical is a listed (CSE) company that aims to develop DMT for addiction treatment.
Overviews of companies in the space
Entheon Biomedical is a listed (CSE) company that aims to develop DMT for addiction treatment.
Synaptic Ventures is a venture fund that aims to take psychedelic companies public (in the US).
Silo Pharma is a for-profit, listed, bio-pharma company aiming to commercialize psychedelics.
Enter Here provides a bridge between researchers and participants for clinical trials with psychedelics.
Source Research Foundation is a non-profit that helps psychedelic researchers by enabling collaboration and grants.
Osmind is a public-benefit corporation (PBC) that assists mental health clinics with software in the treatment of depression, mostly with psychedelics (ketamine).
Gwella Mushroom Inc. is a life sciences company looking to commercialize mushrooms. They are planning to be on the intersection between functional and psychedelic mushrooms.
The Riverstyx Foundation sponsors a variety of psychedelic researchers and conferences.
The Castalia Foundation was founded in 1964 as a center for research on consciousness expansion. The founders include Timothy Leary, Richard Alpert (Ram Dass), Ralph Metzner, and Susan Metzner.
MagicMed is a Canadian company, acquired by Enveric Biosciences, making a molecular derivatives library (Psybrary™) to speed up and develop new psychedelic medicines.